K

E

EQT Lifesciences

Crunchbase
Pitchbook
Crunchbase

Deals on record

21

Common Fundraising Type

Series A

R
ReliaQuest

AI-powered • Security operations

Ten Eleven Ventures logo
KKR logo
FTV Capital logo
EQT logo

ReliaQuest is an AI-powered security operations company that offers the GreyMatter platform to integrate with cybersecurity tools for enhanced threat detection and response.

Equity
$500M
04/01/2025
Article
S
Sequana Medical

Healthtech • Alfapump system

Partners in Equity logo
GEM Global Yield logo
EQT logo

Sequana Medical develops and commercializes the alfapump system, a medical device for managing fluid overload in patients, and is advancing its Direct Sodium Removal therapy.

Hybrid
$26.2M
03/18/2025
Article
P
Perfuze

Medical devices • Catheters

SV Health logo
Seroba logo
EQT Life Sciences logo
Earlybird logo

Perfuze is a medical device company that develops catheters designed to improve stroke treatment by enhancing the trackability and delivery of aspiration catheters.

Equity
$23.9M
03/13/2025
Article
N
Nobi

AI-powered • Smart lights

Nexus NeuroTech Ventures logo
EQT Life Sciences logo
Angelini Ventures logo
15th Rock logo

Nobi develops AI-powered smart lights designed to detect falls and enhance elderly care.

Series B
$36.2M
01/28/2025
Article
T
TravelPerk

Business travel management • Expense management

Noteus Partners logo
Kinnevik logo
General Catalyst logo
EQT Growth logo

TravelPerk is a business travel management platform that integrates travel and expense management into a single solution.

Series E
$200M
01/28/2025
Article
X
XyloCor Therapeutics

Gene therapy • Cardiovascular diseases

Jeito Capital logo
Lumira Ventures logo
Fountain Healthcare Partners logo
EQT logo

XyloCor Therapeutics develops gene therapies for cardiovascular diseases, focusing on treatments for refractory angina and coronary artery bypass graft surgery.

Series B
$67.5M
01/07/2025
Article
N
Nua Surgical

Maternal health • C-section

EQT Life Sciences logo
Texas Medical Center logo
Kidron Capital logo
Enterprise Ireland logo

Nua Surgical is a maternal health company focused on developing and commercializing the SteriCISION C-Section Retractor to improve outcomes in Caesarean-section surgeries.

Series A
$6.9M
12/06/2024
Article
A
ATB Therapeutics

Biologics • Therapeutic Antibodies

EQT Life Sciences logo
V-Bio logo
VIVES Partners logo
Wallonie Entreprendre logo

ATB Therapeutics is a biologics company developing therapeutic antibodies with novel cell-killing mechanisms for oncology and immunology therapies.

Series A
$57.1M
11/19/2024
Article
E
Evommune

Biotechnology • Clinical Development

RA Capital Management logo
Verition Fund Management logo
Symbiosis logo
RTW Investments logo

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Series C
$115M
10/31/2024
Article
N
Neara

Renewable Energy • Infrastructure Modeling

Square Peg Capital logo
Prosus Ventures logo
Partners Group logo
Skip Capital logo

Neara is an AI-powered infrastructure modeling platform that enables utility operators to design efficient networks, manage wildfires and vegetation, expedite renewable projects, and aggregate data into a digital simulation environment, with a focus on overcoming network constraints to the energy transition.

Series C
$31M
10/30/2024
Article
P
PanTera

Radioisotope production • Actinium-225

EQT Life Sciences logo
Paladin logo
PMV logo
Kurma Partners logo

PanTera is a Belgian company focused on producing the radioisotope actinium-225 for use in Targeted Alpha Therapy for cancer treatment.

Hybrid A
$139.7M
09/11/2024
Article
C
Compass

K-12 • SaaS

EQT logo

Compass provides a cloud-based school management platform for K-12 schools, serving over 3,000 institutions and 4 million users globally.

Equity
Undisclosed
08/21/2024
Article
L
LUMA Vision

Medical Device • Cardiac Imaging

imec.xpand logo
EQT Lifesciences logo
Bayern Kapital logo
Atlantic Bridge logo

LUMA Vision is a medical device company specializing in the development of a 4D cardiac imaging and navigation platform called VERAFEYE, currently raising funds to secure FDA approval and commercialize in the U.S. market.

Series A
$22M
12/18/2023
Article
S
Shinobi Therapeutics

Biotechnology • IPS-T cell therapy

F-Prime Capital logo
EQT Life Sciences logo
JIC Venture Growth Investments logo
Fast Track Initiative logo

Shinobi Therapeutics is a biotech company developing off-the-shelf, immune-evasive, induced pluripotent stem cell (iPSC)-derived cell therapies for GPC3+ solid tumor cancers.

Series A
$51M
12/12/2023
Article
K
Klook

Travel Services Platform • Experience Curation

SMIC SG Holdings logo
Golden Vision Capital logo
Krungsri Finnovate logo
Kasikornbank Financial Conglomerate logo

Klook is a travel services platform that curates experiences and services across global destinations, focusing on product innovation, expanding city pass offerings, and integrating AI to enhance its marketing and operational efficiency.

Hybrid
$210M
12/07/2023
Article
N
Nouscom

Clinical-stage immuno-oncology • Cancer immunotherapies

XGen Ventures logo
Versant Ventures logo
Revelation Partners logo
Panakès Partners logo

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.

Series C
$72.5M
11/14/2023
Article
V
VectorY

Biotech • Vectorized Antibody Program

EQT Life Sciences logo
MRL Ventures Fund logo
Insight Partners logo
Forbion Ventures logo

VectorY Therapeutics is a biotech company focused on developing vectorized antibody therapies for neurodegenerative diseases, with a lead program targeting Amyotrophic Lateral Sclerosis (ALS).

Series A
$137.8M
11/13/2023
Article
M
MinervaX

Biotechnology • Maternal Vaccines

EQT Life Sciences logo
OrbiMed logo
Novo Holdings logo
Pureos Ventures logo

MinervaX is a Danish biotechnology company that has raised EUR 54 million to advance the development of its maternal vaccine against Group B Streptococcus (GBS), a leading cause of life-threatening infections in newborns.

Equity
$57.3M
10/11/2023
Article
A
Agomab

Biotech • Anti-fibrotic Therapies

Agomab Therapeutics is a Belgian biotech company developing novel treatments for fibrosis, with a pipeline of growth factor targeting antibodies and small molecule compounds.

Series C
$100.6M
10/11/2023
Article
A
AstronauTx

Biotech • Alzheimer's Disease Treatment

Novartis logo
MPM Capital logo
EQT Life Sciences logo
Dementia Discovery Fund logo

AstronauTx is a London-based biotech company that develops small-molecule drugs for the treatment of Alzheimer's disease, and has raised £48 million ($61 million) in Series A financing to advance its drug portfolio, including conducting a clinical study for its lead program.

Series A
$58.6M
10/09/2023
Article
G
Gympass

Corporate Wellness • Employee Benefits

Neuberger Berman logo
Moore Strategic Ventures logo
General Atlantic logo
EQT Growth logo

Gympass is a corporate wellness platform that offers a comprehensive employee benefit providing access to a network of gyms, studios, classes, personal trainers, and wellness apps.

Series F
$85M
08/23/2023
Article